Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Patent Application Number 17136870

17136870
Not Appealed
Patent NumberUS 11744816 B2
Publication NumberUS 20210361605 A1
Filled DateDec 29, 2020
Priority DateMar 13, 2015
Inventor/ApplicantsNoah Rosenberg
Roger Schofield Newton
Diane Elaine MacDougall
Noah Laban Rosenberg
ExaminesKANTAMNENI, SHOBHA
Art Unit1627
Technology Center1600
Assignments
Esperion Therapeutics Inc.
Current
Esperion Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.